The influences of CD14 -260C>T polymorphism on survival in ICU critically ill patients

Immunological Investigations

Volumn 38, Issue 8, 2009, Pages 797-811

  Fallavena, Paulo R V ^a   Borges, Thiago J ^a   Paskulin, Diego D ^a   Paludo, Francis J O ^a   Goetze, Thayse B ^a   De Oliveira, Jarbas R ^a   Nóbrega, Otávio T ^b   Dias, Fernando S ^a   Alho, Clarice S ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Mortality

Indexed keywords

CD14 ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; CRITICAL ILLNESS; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNITY, INNATE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS;

EID: 70350776764     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820130903258818     Document Type: Article

References (46)

1. Agnese, D. M., Calvano, J. E., Hahm, S. J., Coyle, S. M., Corbett, S. A., Calvano, S. E., Lowry, S. F. (2002). Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522-1525.
2. Aguiar, B. B., Girardi, I., Paskulin, D. D., França, E., Dornelles, C., Dias, F. S., Bonorino, C., Alho, C. S. (2008). CD14 Expression in the First 24h of Sepsis: Effect of ?260C>T CD14 SNP. Immunol. Inv. 37:1-18.
3. Baldini, M., Lohman, C., Halonen, M., Erickson, R. P., Holt, P. G., Martinez, F. D. (1999). A polymorphism in the 5¢ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immmunoglobulin E. Am. J. Respir. Cell. Mol. Biol. 20:976-983.
4. Barber, R. C., Aragaki, C. C., Chang, L. E., Purdue, G. F., Hunt, J. L., Arnoldo, B. D., Horton, J. W. (2007). CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock 27(3):232-237.
5. Barber, R. C., Chang, L. Y., Arnoldo, B. D., Purdue, G. F., Hunt, J. L., Horton, J. W., Aragaki, C. C. (2006). Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 4:250-255.
6. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M., Sibbald, W. J. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655.
7. Brunialti, M. K. C., Martins, P. S., Carvalho, H. B., Machado, F. R., Barbosa, L. M., Salomao, R. (2006). TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25(4):351-357.
8. Burgmann, H., Winkler, S., Locker, G. J., Presterl, E., Laczika, K., Staudinger, T., Staudinger, T., Knapp, S., Thalhammer, F., Wenisch, C., Zedwitz-Liebenstein, K., Frass, M., Graninger, W. (1996). Increased serum concentration of soluble CD14 is a prognostic marker in gram-positive sepsis. Clin. Immunol. Immunopathol. 80:307-310.
9. Calvano, J. E., Agnese, D. M., Um, J. Y., Goshima, M., Singhal, R., Coyle, S. M., Reddell, M. T., Kumar, A., Calvano, S. E., Lowry, S. F. (2003). Modulation of The Lipopolysaccharide Receptor Complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance. Shock 20(5):415-419.
10. Carrillo, E. H., Gordon, L., Goode, E., Davis, E., Polk, H. C. (2001). Early elevation of soluble CD14 may help identify trauma patients at high risk for infection. J. Trauma 50:810-815.
11. D'Avila, L. C., Albarus, M. H., Franco, C. R., Aguiar, B. B., Oliveira, J. R., Dias, F. S., Alho, C. S. (2006). Effect of CD14 ?260C>T polymorphism on the mortality of critically ill patients. Immunol. Cell. Biol. 84(3):342-348.
12. Dziarsky, R., Tapping, R. I., Tobias, P. S. (1998). Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680-8690.
13. Ertel, W., Kremer, J. P., Steckholzer, U., Jarrar, D., Trentz, O., Schildberg, F. W. (1995). Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347.
14. Fan, X., Stelter, F., Menzel, R., Jack, R., Spreitzer, I., Hartung, T., Schütt, C. (1999). Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein dependent reaction. Infect. Immun. 67(6):2964-2968.
15. Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B., Wright, S. D. (1992). Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176(6):1665-1671.
16. Gibot, S., Cariou, A., Drouet, L., Rossignol, M., Ripoll, L. (2002) Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit. Care Med. 30:969-973.
17. Glück, T., Silver, J., Epstein, M., Cao, P., Farber, B., Goyert, S. M. (2001). Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis. Eur. J. Med. Res. 6:351-358.
18. Goyert, S. M., Ferrero, E., Rettig, W. J., Yenamandra, A. K., Obata, F., Le Beau, M. M. (1998). The CD14 monocyte differentiation antigen maps to region encoding growth factors and receptors. Science 239:497-500.
19. Gupta, D., Kirkland, T. N., Viriyakosol, S., Dziarski, R. (1996). CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271: 23310-23316.
20. Heesen, M., Bloemeke, B., Schade, U., Obertacke, U., Majetschak, M. (2002). The ?260-C/T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intens. Care Med. 28: 1161-1163.
21. Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D (2001). Lack of association between the -260 C -T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intens. Care Med. 27(11):1770-1775.
22. Hiki, N., Berger, D., Prigl, C., Boelke, E., Wiedeck, H., Seidelmann, M., Staib, L., Kaminishi, M., Oohara, T., Beger, H. G. (1998). Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. Infect. Immun. 66:1135-1141.
23. Hubacek, J. A., Rothe, G., Pit'ha, J., Skodová, Z., Stanek, V., Poledne, R., Schmitz, G. (1999). C (?260)/T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220.
24. Hubacek, J. A., Stuber, F., Frohlich, D., Book, M., Wetegrove, S., Rothe, G., Schmitz, G. (2000). The common functional C(?159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 1:405-407.
25. Jersmann, H. P. A. (2005). Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol. Cell. Biol. 83:462-467.
26. Kabesch, M., Hasemann, K., Schickinger, V., Tzotcheva, I., Bohnert, A., Carr, D., Baldini, M., Hackstein, H., Leupold, W., Weiland, S.K., Martinez, F.D., Mutius, E., Bein, G. (2004). A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE on atopic disease. Allergy 59:520-525.
27. Karhukorpi, J., Yanm Y., Niemelä, S., Valtonen, J., Koistinen, P., Joensuu, T., Saikku, P., Karttunen, R. (2002). Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin. Exp. Immunol. 128:326-332.
28. Knaus, W. A., Draper, E. A., Wagner, D. P., Zimmerman, J. E. (1985). APACHE II: A severity of disease classification system. Crit. Care Med. 13:818-829.
29. Koch, W., Kastrati, A., Mehilli, J., von Beckerath, N., Schomig, A. (2002). CD14 gene - 159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am. Heart J. 143: 950-951.
30. Koenig, W., Khuseyinova, N., Hoffmann, M.M., März, W., Fröhlich, M., Hoffmeister, A., Brenner, H., Rothenbacher, D. (2002). CD14 C(-260)/T polymorphism plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J. Am. Coll. Cardiol. 40:34-42.
31. Lahiri, D. K., Nurnberger, J. I. Jr. (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl. Acids Res. 19:5444.
32. Landmann, R., Reber, A. M., Sansano, S., Zimmerli, W. (1996). Function of soluble CD14 in serum from patients with septic shock. J. Infect. Dis. 173:661-668.
33. Landmann, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A., Glauser, M. P., Calandra, T. (1995). Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171(3):639-644.
34. Le-Barillec, K., Si-Tahar, M., Balloy, V., Chignard, M. (1999). Proteolysis of monocyte CD14 by human leucocyte elastase inhibits lipopolysaccharide-mediated cell activation. J. Clin. Invest. 103:1039-1046.
35. Le Van, T. D., Bloom, J. W., Bailey, T. J., Karp, C. L., Halonen, M., Martinez, F. D., Vercelli, D. (2001). A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167(10):5838-5844.
36. Lin, J., Yao, Y., Yu, Y., Chai, J., Huang, Z., Dong, N., Sheng, Z. Y. (2007). Effects of CD14-159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture. Shock 28(2):148-153.
37. Lin, J., Yao, Y. M., Huang, Z. H., Hou, X. X., Zhu, J. M., Chai, J. K. (2004). Association between a genomic polymorphism within the CD14 locus and severe sepsis susceptibility as well as prognosis in patients after extensive burns. Zhongguo. Wei. Zhong. Bing. Ji. Jiu. Yi. Xue. 16:271-273.
38. Moraes, J. F. D., Souza, V. B. A. (2005). Factors associated with the successful aging of the socially-active elderly in the metropolitan region of Porto Alegre. Rev. Bras. Psiquiatr. 27:302-308.
39. Nauck, M., Winkelmann, B. R., Hoffmann, M. M., Böhm, B. O., Wieland, H., März, W. (2002). C(?260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Am. J. Cardiol. 90(11):1249-1252.
40. Rivera-Chavez, F. A., Peters-Hybki, D. L., Barber, R. C., Lindberg, G. M., Jialal, I., Munford, R. S., O'Keefe, G. E. (2004). Innate immunity genes influence the severity of acute appendicitis. Ann. Surg. 240:269-277.
41. Schütt, C. (1999). Molecules in focus: CD14. Inter. J. Cell. Biol. 31:45-49.
42. Tsujimoto, H., Ono, S., Majima, T., Kawarabayashi, N., Takayama, E., Kinoshita, M., Seki, S., Hiraide, H., Moldawer, L. L., Mochizuki, H. (2005). Neutrophil elastase, Mip-2, And Tlr-4 expression during human and experimental sepsis. Shock 23(1):39-44.
43. Vincent, J. L., Ferreira, F. L. (2002). Multiple organ failure: Clinical syndrome. In: Evans TW, Fink MP, eds. Mechanisms of Organ Dysfunction in Critical Illness. Verlag Berlin Heidelberg: Intensive Care Medicine Springer; 394-403.
44. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
45. Zhang, D. E., Hetherington, C. J., Tan, S., Dziennis, S. E., Gonzalez, D. A., Chen, H. M., Tenen, D. G. (1994). Sp1 is critical factor for the monocyte specific expression of human CD14. J. Biol. Chem. 269(11):425-434.
46. Ziegler-Heitbrock, H. W. L., Ulevitch, R. J. (1993). CD14: Cell surface receptor and differentiation marker. Immunol. Today 14(3):121-125.